SCHEMBL30593162

SCHEMBL30593162

FC(F)(F)c1cc(Cl)c(Br)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NT5E P21589 1/20 0.41
TRPV4 Q9HBA0 1/20 0.39
CA2 P00918 1/20 0.38
CHKA P35790 1/20 0.38
LOXL2 Q9Y4K0 2/20 0.37
LOX P28300 1/20 0.36
ABL1 P00519 2/20 0.36
BCR P11274 2/20 0.36
ALDH1A1 P00352 3/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CASP3 P42574 1/20 0.33
KMT2A Q03164 1/20 0.33
SMARCA2 P51531 1/20 0.33
SMARCA4 P51532 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
PLAU P00749 2/20 0.33
KDM4E B2RXH2 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26608262 1.00 NT5E (0.41) NT5ETRPV4CA2CHKALOXL2
SCHEMBL25272114 0.85 NT5E (0.40) NT5ETRPV4CA2CHKALOXL2
SCHEMBL31119088 0.78 TRPV4 (0.39) NT5ETRPV4CA2CHKALOXL2
SCHEMBL17574583 0.78 TRPV4 (0.39) NT5ETRPV4CA2CHKALOXL2
SCHEMBL19899650 0.77 CA2 (0.45) TRPV4CA2CHKALOXL2LOX
SCHEMBL22448607 0.77 TRPV4 (0.38) TRPV4CA2CHKALOXL2LOX
SCHEMBL30456789 0.77 HSP90AA1 (0.38) TRPV4CA2CHKALOXL2LOX
SCHEMBL2998384 0.77 HSP90AA1 (0.38) TRPV4CA2CHKALOXL2LOX
SCHEMBL3451192 0.77 TRPV4 (0.38) TRPV4CA2CHKALOXL2LOX
SCHEMBL16139569 0.74 TRPV4 (0.39) NT5ETRPV4CA2CHKALOXL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119677737-A Heteroaryl compounds for the treatment of pain 沃泰克斯药物股份有限公司 2025-03-21 CN disclosed
CN-119546580-A Heteroaryl compounds for the treatment of pain 沃泰克斯药物股份有限公司 2025-02-28 CN disclosed
EP-4511115-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN Vertex Pharmaceuticals Incorporated (US) 2025-02-26 EP disclosed
WO-2023205468-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 WO disclosed